LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19.

    Brunsdon, Priya / Saluja, Bhawana / Sahajwalla, Chandrahas

    Journal of clinical pharmacology

    2020  Volume 60, Issue 9, Page(s) 1147–1154

    Abstract: Numerous drugs are being investigated for the treatment of COVID-19, including antivirals and therapies targeting complications related to COVID-19. The clinical presentation of COVID-19 varies from mild fever, cough, and dyspnea in the early stages of ... ...

    Abstract Numerous drugs are being investigated for the treatment of COVID-19, including antivirals and therapies targeting complications related to COVID-19. The clinical presentation of COVID-19 varies from mild fever, cough, and dyspnea in the early stages of disease to severe complications such as acute respiratory distress syndrome, systemic hyperinflammation, and sepsis. A thorough understanding of the disease pathogenesis and the disease complications is essential to developing effective therapies to treat this potentially life-threatening disease. This review offers key clinical pharmacology considerations involved in the development of small molecules for the treatment of COVID-19. They are based on the major observed disease complications that impact drug absorption, distribution, metabolism, and elimination. We also address considerations regarding potential drug interactions, alternative routes and methods of administration, and dosing in patients on hemodialysis.
    MeSH term(s) Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/complications ; COVID-19/drug therapy ; COVID-19/virology ; Drug Development ; Drug Interactions ; Humans
    Chemical Substances Antiviral Agents
    Keywords covid19
    Language English
    Publishing date 2020-07-12
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.1697
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical Pharmacology Considerations for Developing Small‐Molecule Treatments for COVID‐19

    Brunsdon, Priya / Saluja, Bhawana / Sahajwalla, Chandrahas

    The Journal of Clinical Pharmacology

    2020  Volume 60, Issue 9, Page(s) 1147–1154

    Keywords Pharmacology (medical) ; Pharmacology ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.1697
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19

    Brunsdon, Priya / Saluja, Bhawana / Sahajwalla, Chandrahas

    J. clin. pharmacol

    Abstract: Numerous drugs are being investigated for the treatment of COVID-19, including antivirals and therapies targeting complications related to COVID-19. The clinical presentation of COVID-19 varies from mild fever, cough, and dyspnea in the early stages of ... ...

    Abstract Numerous drugs are being investigated for the treatment of COVID-19, including antivirals and therapies targeting complications related to COVID-19. The clinical presentation of COVID-19 varies from mild fever, cough, and dyspnea in the early stages of disease to severe complications such as acute respiratory distress syndrome, systemic hyperinflammation, and sepsis. A thorough understanding of the disease pathogenesis and the disease complications is essential to developing effective therapies to treat this potentially life-threatening disease. This review offers key clinical pharmacology considerations involved in the development of small molecules for the treatment of COVID-19. They are based on the major observed disease complications that impact drug absorption, distribution, metabolism, and elimination. We also address considerations regarding potential drug interactions, alternative routes and methods of administration, and dosing in patients on hemodialysis.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #613342
    Database COVID19

    Kategorien

To top